Policy, Licensing and Copyright

The JEMHS is an open-access journal. All articles are freely available for download and can be accessed globally. The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, as well as a license to copy, use, distribute, transmit, and display the work publicly, as well as to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper credit of authorship.

  • The JEMHS follows the CC BY license (Creative Commons Attribution v4.0 International License) for its open access journal
  • Copyright on any open access article in the JEMHS published by International Scientific Research & Journal Publications (ISRJP) is retained by the author(s).
  • Author(s) grant International Scientific research & Journal Publications (ISRJP) a license to publish the article and recognize it as original publisher.
  • Permission is required to reproduce material (such as illustrations) from the copyright holder.  Articles cannot be published without these permissions.

Plagiarism Policy

The plagiarism is defined as: "to steal and pass off the ideas or words of another as one's own", "use another's production without crediting the source" or "present as new and original of an idea or product derived from an existing source". JEMHS also defines "self-plagiarism" as a type of plagiarism. The manuscript management system includes plagiarism check software for our Editors and Reviewers. Manuscript with more than 20% plagiarism will be rejected. Authors are encouraged to check plagiarism before submission.

Informed Consent Policy

JEMHS requires all research involving human participants complies with the principles outlined in the Declaration of Helsinki and with all applicable national, institutional, and local regulations. A statement indicating that such consent was obtained must be included in the 'Methods' section of your manuscript. Potential participants should make their own decisions about whether or not to engage in the research. This should be accomplished through a process of informed consent in which individuals (1) are accurately informed of the research's purpose, methods, risks, benefits, and alternatives, (2) understand this information and how it relates to their own clinical situation or interests, and (3) make a voluntary decision to participate. 

Policy on Artificial Intelligence Used Manuscripts

Following WAME's (World Association of Medical Editors) recommendations:

  • AI tools (e.g., ChatGPT or LLM based bots) can not be listed as authors
  • Any AI use in research, writing, or image preparation must be disclosed in the manuscript
  • Authors are fully responsible for accuracy, originality, and absence of plagiarism, regardless of AI use

Ethics Committee Approval

  • Human studies require Institutional Review Board (IRB) approval, with protocol number stated in the manuscript
  • Clinical trials must indicate regulatory approval (e.g., FDA or equivalent)
  • Animal studies require approval from the institutional animal ethics committee
  • Research involving humans should comply with the Declaration of Helsinki.